Nuzenio

Tipranks Phil Nadeau

Tipranks Phil Nadeau news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 2 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 16:34:38 GMTAnalyst Reiterates Buy on Vir Biotechnology, Citing Advancing Hepatitis D and Oncology Pipelines and Strong Cash Runway - TipRanks
Thu, 06 Aug 2026 10:36:07 GMTPhil Nadeau Reiterates Buy on Editas Medicine, Citing Strong Cash Runway and Upcoming EDIT-401 Clinical Catalyst - TipRanks
Wed, 05 Aug 2026 13:54:00 GMTVertex Pharmaceuticals (VRTX) Gets a Buy from Wells Fargo - The Globe and Mail
Tue, 04 Aug 2026 07:00:00 GMTPhil Nadeau Reiterates Buy on Syndax, Citing Strong Revuforj Trajectory and Potential $2B Peak U.S. Sales - TipRanks
Fri, 31 Jul 2026 07:00:00 GMTRBC Capital Sticks to Their Buy Rating for Biogen (BIIB) - The Globe and Mail
Fri, 31 Jul 2026 04:24:17 GMTPhil Nadeau Raises Neurocrine Price Target to $220 on Exceptional Q2 Beat and Strength Across Ingrezza and Crenessity - TipRanks

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tipranks Phil Nadeau.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

2 distinct publisher/source names are currently connected to this entity page.